CRYPTO GETS HIT, RED PREMARKETS, TOM LEE BUYS MORE ETH, EU MEETING WITH TRUMP TODAY | MARKET OPEN
CRYPTO GETS HIT, RED PREMARKETS, TOM LEE BUYS MORE ETH, EU MEETING WITH TRUMP TODAY | MARKET OPEN
264 days agoAmit Kukreja@amitinvesting
YouTube2 hr 48 min
Watch on YouTube
Note: AI-generated summary based on third-party content. Not financial advice. Read more.
Quick Insights

Consider buying Robinhood (HOOD) ahead of its "Hood Month" product announcements and international expansion into Dubai. For discounted exposure to Ethereum, look at Sharplink Gaming (SBET), which trades below the value of its crypto holdings. Following legendary investor Stan Druckenmiller, investors may find value in small-cap stocks (IWM), which could rally on future interest rate cuts. Be cautious with Hims & Hers Health (HIMS) as it faces a significant new competitive threat from Novo Nordisk's (NVO) cheaper weight-loss drug offering. The recent dip in Ethereum (ETH) is viewed as a buying opportunity, supported by record institutional inflows and a favorable long-term outlook.

Detailed Analysis

Ethereum (ETH)

  • The speaker expressed a bullish sentiment on Ethereum, viewing the recent price drop as a buying opportunity rather than a fundamental problem.
  • The dip was attributed to algorithm-driven liquidations, which cleared out leverage and provided a lower entry point for long-term investors like Tom Lee.
  • Key bullish factors mentioned:
    • Institutional Adoption: Ethereum saw over $2 billion in net inflows from institutional investors last week, a record amount.
    • Regulatory Tailwinds: The "Genius Act" was mentioned as a positive development that could increase the use of Ethereum for stablecoins and asset tokenization.
    • Macro Hedge: The speaker believes that as long as the government continues "infinite money printing," assets like Ethereum and Bitcoin will sustain their value.

Takeaways

  • The long-term outlook for Ethereum is considered positive due to strong institutional demand and a favorable regulatory environment.
  • The speaker suggests that recent price weakness is a chance to accumulate the asset at a discount, following the lead of major investors.
  • A significant risk factor is the upcoming Federal Reserve interest rate decision. If the Fed does not cut rates, it could negatively impact ETH and other "risk-on" assets in the short term.

Bitcoin (BTC)

  • The price was noted to be below $116,000 after a wave of liquidations hit the crypto market.
  • The primary investment thesis for Bitcoin remains its role as a hedge against inflation and currency debasement from government money printing.

Takeaways

  • Bitcoin is positioned as a long-term store of value. Its performance is closely tied to macroeconomic trends, particularly inflation and monetary policy.
  • Like Ethereum, its short-term price is sensitive to the Federal Reserve's actions on interest rates.

Crypto-Related Stocks

Bitmine (BMNR)

  • BMNR announced the purchase of another 300,000 ETH, bringing its total holdings to 1.52 million ETH.
  • It is now the world's largest corporate holder of Ethereum.
  • The stock trades at a significant premium to the value of its assets, around 1.5 times its Net Asset Value (NAV). This premium is largely attributed to the influence and constant advocacy of its CEO, Tom Lee.

Takeaways

  • BMNR is a leveraged way to invest in Ethereum. You are betting not only on the price of ETH but also on the company's ability to maintain its high premium, driven by Tom Lee's reputation.
  • While more expensive than buying ETH directly or through other treasury stocks, it offers a simple way to gain exposure through a traditional stock brokerage.

Sharplink Gaming (SBET)

  • In contrast to BMNR, SBET trades below the value of the Ethereum it holds, at roughly 0.95 times its NAV.
  • It holds a substantial amount of Ethereum (728,000 ETH), about half of what BMNR owns.
  • The speaker noted that while it appears to be a better financial bargain, it lacks a high-profile advocate like Tom Lee, which may explain why it trades at a discount.

Takeaways

  • SBET presents a potential value opportunity to buy exposure to Ethereum for less than its market price.
  • The risk is that the stock could continue to trade at a discount without a specific catalyst to attract more investor attention. It's a "value play" versus the "premium play" of BMNR.

MicroStrategy (MSTR)

  • Mentioned as the largest global crypto treasury, reinforcing its status as a premier Bitcoin proxy stock.
  • The company continues its strategy of accumulation, having just bought another 430 BTC.

Takeaways

  • MSTR remains a primary vehicle for investors seeking leveraged exposure to Bitcoin through the stock market. Its strategy is simple and consistent: buy and hold BTC.

Robinhood (HOOD)

  • Major Catalyst Revealed: The speaker shared exclusive news that Robinhood has applied for a license to operate in Dubai and has hired a senior executive to lead its Middle East and North Africa (MENA) expansion.
  • This is part of a broader international push, with a Singapore launch also planned for the end of the year.
  • The company is launching "Hood Month" starting tomorrow, which will feature three "mystery drops" or new product announcements over the next two weeks.
  • The stock has shown strength by maintaining a price level above $100.

Takeaways

  • The speaker is highly bullish on HOOD, citing multiple near-term catalysts that the market may not have priced in yet, especially the expansion into Dubai.
  • Investors should watch for announcements related to "Hood Month" and any official news on international launches, as these could drive the stock higher.

GLP-1 and Healthcare Stocks

Novo Nordisk (NVO)

  • The stock was up over 5% on news that it will offer Ozempic directly to cash-paying patients for $499 a month.
  • This price is roughly half the drug's official list price and is seen as a strategic move to compete with cheaper, compounded alternatives and improve patient access.

Takeaways

  • This is a bullish development for NVO. By making its flagship drug more affordable, it can capture a wider market and defend its market share against competitors.

Hims & Hers Health (HIMS)

  • The stock was down following the Novo Nordisk news, which presents a direct competitive threat to HIMS's business of selling cheaper, compounded weight-loss drugs.
  • HIMS also received a downgrade from Truist, which lowered its price target to $37 from $48, citing concerns about future revenue growth.
  • It was also noted that the CEO has been selling shares.

Takeaways

  • The competitive landscape is heating up for HIMS. Novo Nordisk's price cut creates a significant headwind. Investors should be cautious and monitor how this new dynamic affects HIMS's growth and profitability.

Palantir (PLTR)

  • Well-known short-seller Andrew Left of Citron Research has publicly stated he is shorting PLTR, calling a $40 price target "generous."
  • The bear case is based on the argument that Palantir's valuation is excessively high and detached from fundamentals, especially when compared to a company like OpenAI.

Takeaways

  • Palantir is a "battleground stock" with strong opinions on both sides.
  • The primary risk is its high valuation. The stock trades at a premium, and investors are betting that its future growth in the AI sector will justify this price. The presence of a vocal short-seller could create additional volatility.

Google (GOOGL)

  • A detailed short thesis from investor Chris Camillo was discussed. The core argument is that Google's search query growth numbers may be artificially inflated by automated searches from AI chatbots, not real human users.
  • The concern is that this could be masking a slowdown in human search activity and that advertisers may be paying for low-quality, AI-generated clicks.

Takeaways

  • This is a new and potentially serious bear case for Google. If these claims are true and advertisers begin to pull back their spending due to poor returns, it could negatively impact Google's core revenue stream.
  • This is a key narrative for investors to monitor. Any signs of weakness in ad revenue in future earnings reports could give this thesis more credibility.

General Market and Investment Themes

Small-Cap Stocks (Russell 2000 / IWM)

  • Legendary investor Stan Druckenmiller was reported to be buying small-cap stocks, signaling a potential opportunity in this area.
  • The thesis is that small-cap companies, which are more sensitive to borrowing costs, would be major beneficiaries of a Federal Reserve interest rate cut.
  • It was highlighted that the entire Russell 2000 index of small companies is worth less than single mega-cap tech stocks like NVIDIA or Apple, suggesting they may be undervalued.

Takeaways

  • Small-cap stocks could be a "catch-up" trade. If the Fed begins cutting rates, this sector could outperform the broader market. Investors looking for diversification away from mega-cap tech may find opportunities here.

AI Infrastructure and Data Centers

  • Applied Digital (APLD) stock surged 17% after announcing it will build a new $3 billion AI data center.
  • A chart was shown indicating that construction spending on data centers is on track to surpass spending on general office construction.

Takeaways

  • The AI boom is fueling a massive arms race in building physical infrastructure. Companies involved in building or operating data centers are direct beneficiaries.
  • This trend provides a tailwind for the entire AI ecosystem, from the data center operators (APLD, VST) to the chipmakers whose products fill them (NVIDIA, AMD).
Ask about this postAnswers are grounded in this post's content.
Video Description
twitter: https://x.com/amitisinvesting 00:00 - Intro 07:00 - ETH 17:28 - Macro 24:30 - Professor Speaks 33:34 - HOOD 44:00 - Market Open 1:17:00 - NAHB 1:38:00 - Trump EU Meeting 2:08:00 - PANW update 2:11:00 - Novo 2:31:00 - Yardeni
About Amit Kukreja
Amit Kukreja

Amit Kukreja

By @amitinvesting

Breaking down stocks, business, tech. Thank you for following along the journey!